While Wood is buying, Morgan Stanley, JPMorgan Chase, and Goldman Sachs are arranging sales of up to $10 billion of CoreWeave stock as the IPO lock-up ends. Cathie Wood, head of Ark Investment ...

CoreWeave ($CRWV) stock has plunged nearly 33% since the company announced its second-quarter results. The artificial ...

Cathie Wood's recent buying activity suggests she sees national security technology as an emerging theme -- one that sits ...

ARK’s ARKK ETF also added 165,024 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) to its portfolio, valued at $9,706,711. The ...